'Novel way to create molecules for new drugs'

Image
Press Trust of India Washington
Last Updated : Oct 15 2018 | 12:15 PM IST

Scientists have developed a sustainable way to generate molecules that can enable the design of new types of synthetic drugs.

The researchers at The Ohio State University in the US said this new method of forming reactive intermediates called ketyl radicals offers a way to use catalysts to convert simple molecules into complex structures in one chemical reaction.

This is done in a less harsh, more sustainable and waste-free manner, according to the study published in the journal Science.

"The previous strategy for creating ketyl radicals is about a century old. We have a found a complementary way to access ketyl radicals using LED lights for the synthesis of complex, drug-like molecules," said David Nagib, an assistant professor at The Ohio State University.

"The story starts with carbonyls, compounds that function as one of the most common building blocks in creating potential new drugs," said Nagib.

Unlike classic carbonyl chemistry taught in introductory organic textbooks, when carbonyls are converted to their "radical" form, they become much more reactive.

These radicals, containing an unpaired electron desperately seeking its partner, enable researchers to form new bonds, in order to create complex, drug-like products.

Until now, ketyl radical formation has required strong, harsh substances called reductants, like sodium or samarium, to act as catalysts.

These reductants can be toxic, expensive and incompatible with creating medicines, Nagib said.

In this study, the researchers found a way to use manganese as a catalyst that could be activated with a simple LED light.

"Manganese is very cheap and abundant, which makes it an excellent catalyst. Also, it allows us to access radicals by a complementary atom-transfer mechanism, rather than the classic electron-transfer mechanism," he said.

Not only is manganese cheaper and more abundant, it actually is more selective in creating products with defined geometries, so they can fit into drug targets, the study found.

The process is less wasteful, as well, recycling the iodine atom used to make the radicals by including it in the more functional products.

This new method to generate ketyl radicals enables researchers to create more versatile and complex structures that could be useful in generating new medicines, Nagib said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 15 2018 | 12:15 PM IST

Next Story